| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 16.406 | 12.220 | 6.179 | 9.323 | 20.275 | 15.111 | 0 | 0 | 3.648 |
| Total Income - EUR | 0 | 16.777 | 12.263 | 10.511 | 18.857 | 26.491 | 21.583 | 10.747 | 10.311 | 12.493 |
| Total Expenses - EUR | 8 | 15.823 | 11.200 | 9.786 | 18.235 | 26.022 | 21.178 | 10.441 | 9.977 | 12.172 |
| Gross Profit/Loss - EUR | -8 | 954 | 1.063 | 725 | 621 | 469 | 405 | 306 | 334 | 322 |
| Net Profit/Loss - EUR | -8 | 456 | 929 | 620 | 433 | 224 | 206 | 211 | 242 | 210 |
| Employees | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Atropatian R&D Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 16 | 856 | 577 | 905 | 383 | 64 | 0 | 0 | 0 | 764 |
| Current Assets | 45 | 595 | 2.341 | 8.821 | 4.348 | 4.780 | 4.594 | 3.262 | 4.014 | 3.900 |
| Inventories | 0 | 15 | 10 | 1.602 | 3.081 | 4.591 | 4.490 | 2.965 | 2.956 | 2.940 |
| Receivables | 0 | 36 | 1.342 | 4.251 | 1.255 | 152 | 49 | 280 | 757 | 951 |
| Cash | 45 | 544 | 989 | 2.967 | 12 | 37 | 55 | 17 | 301 | 9 |
| Shareholders Funds | 37 | 492 | 1.413 | 2.007 | 2.402 | 2.580 | 2.729 | 2.948 | 3.181 | 3.374 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 24 | 959 | 1.505 | 7.718 | 2.330 | 2.263 | 1.865 | 314 | 833 | 1.290 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4664 - 4664" | |||||||||
| CAEN Financial Year |
4664
|
|||||||||
Comments - Atropatian R&D Srl